[1]李晓梅,吴晓兵,于文姣.补虚活血通络方联合噻托溴铵治疗COPD迁延期临床疗效及其作用机制[J].西部中医药,2022,35(01):112-115.[doi:10.12174/j.issn.2096-9600.2022.01.27]
 LI Xiaomei,WU Xiaobing,YU Wenjiao.Clinical Effects of Deficiency-tonifying Blood-activating Collateral-dredging Prescription and Tiotropium Bromide in the Treatment of COPD at Middle Later Stage and Its Mechanism[J].Western Journal of Traditional Chinese Medicine,2022,35(01):112-115.[doi:10.12174/j.issn.2096-9600.2022.01.27]
点击复制

补虚活血通络方联合噻托溴铵治疗COPD迁延期临床疗效及其作用机制
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年01期
页码:
112-115
栏目:
衷中参西
出版日期:
2022-01-15

文章信息/Info

Title:
Clinical Effects of Deficiency-tonifying Blood-activating Collateral-dredging Prescription and Tiotropium Bromide in the Treatment of COPD at Middle Later Stage and Its Mechanism
作者:
李晓梅 吴晓兵 于文姣
辽宁中医药大学附属第二医院,辽宁 沈阳 110034
Author(s):
LI Xiaomei WU Xiaobing YU Wenjiao
The Second Affiliated Hospital to Liaoning University of Traditional Chinese Medicine, Shenyang 110034, China
关键词:
慢性阻塞性肺疾病LTB4IL-8补虚活血通络方噻托溴铵
Keywords:
COPDLTB-4IL-8deficiency-tonifying blood-activating collateral-dredging prescriptiontiotropium bromide
分类号:
R562.2
DOI:
10.12174/j.issn.2096-9600.2022.01.27
摘要:
目的探讨补虚活血通络方联合噻托溴铵治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)迁延期的临床疗效及对血清白三烯B4(leukotriene B4,LTB4)、白细胞介素8(interleukin-8,IL-8)水平的影响。 方法将85例COPD迁延期患者随机分为两组,因随访失败,最终联合组和单一组各40例,单一组行噻托溴铵粉吸入剂治疗,必要时予机械通气,联合组在单一组基础上予补虚活血通络方,观察治疗前后两组患者血清LTB4与IL-8水平、肺功能检测、嗜酸性粒细胞(eosinophilic granulocyte,EOS)计数及圣乔治呼吸问卷(St George’s Respiratory Questionnaire,SGRQ)与6 min步行距离实验(6minute walking distance,6MWD)问卷评分,并观察疗效。 结果两组治疗后血清LTB4与IL-8水平、SGRQ与6MWD问卷评分、用力肺活量(forced expiratory volume,FEV)、1秒用力呼气容积(forced expiratory volume in one second,FEV1)、呼气峰流量(peak expiratory flow,PEF)及临床疗效联合组优于单一组(P<0.05)。 结论补虚活血通络方联合噻托溴铵治疗COPD迁延期效果优于单纯噻托溴铵治疗,能减轻患者症状,改善相关指标。
Abstract:
ObjectiveTo investigate clinical effects of deficiency-tonifying blood-activating collateral-dredging prescription and tiotropium bromide in the treatment of COPD at middle later stage and its influence on the levels of serum LTB4 and IL-8. MethodsAll 85 patients were randmized into two groups, the combination group and the single group with 40 cases in each group consequently due to follow-up failure, the single group was treated by tiotropium bromide powder inhalant, mechanical ventiilation if necessary, the combination group took deficiency-tonifying blood-activating collateral-dredging prescription based on the therapy the single group accepted, to observe the levels of serum LTB4/IL-8, the detection of pulmonary function, EOS count and the scores of SGRQ, 6MWD questionaire before and after treating, to assess clinical effects. ResultsAfter treating, the levels of serum LTB-4/IL-8, the scores of SGRQ, 6MWD questionaire, FEV, FEV1, PEF and clinical effects of the combination group were superior to these of the single group (P<0.05). ConclusionDeficiency-tonifying blood-activating collateral-dredging prescription and tiotropium bromide in the treatment of COPD at middle later stage is superior to single Western medicine, it could relieve the symptoms and improve the related indexes.

相似文献/References:

[1]严文有,李有成△,赵斌庆,等.僵卿金沸草散治疗咳嗽变异性哮喘疗效观察[J].西部中医药,2014,27(09):97.
[2]王萍.慢性阻塞性肺病患者实施临床护理路径的疗效分析[J].西部中医药,2014,27(11):140.
[3]王 燕,孙凤英,倪 军.慢性阻塞性肺疾病患者非药物治疗依从性与生活质量相关性的研究[J].西部中医药,2015,28(03):89.
[4]郭晓燕,尹广超,陆城华,等.川芎平喘合剂对COPD患者血管内皮功能的调节作用[J].西部中医药,2015,28(05):1.
[5]王振伟,杨佩兰,沈丽,等.百部养肺煎膏治疗COPD稳定期患者的临床研究[J].西部中医药,2015,28(05):56.
[6]赵宇冰,林丽明.老年慢性阻塞性肺疾病患者缓解期的社区康复治疗[J].西部中医药,2012,25(08):59.
 ZHAO Yu-bing,LIN Li-ming.Community Rehabilitation Therapy for Senile Patients with COPD at Remission Stage[J].Western Journal of Traditional Chinese Medicine,2012,25(01):59.
[7]张旭辉,杨虹.咳喘宁胶囊治疗稳定期慢性阻塞性肺疾病的疗效评价[J].西部中医药,2016,29(03):1.
 ZHANG Xuhui,YANG Hong.Evaluation of Clinical Effects of KeChuanNing Capsules in Treating Chronic Obstructive Pulmonary Disease at Stable Stage[J].Western Journal of Traditional Chinese Medicine,2016,29(01):1.
[8]晏燕,孙建勤,姜冰玉,等.中西医结合治疗老年慢性阻塞性肺疾病急性加重期的临床疗效[J].西部中医药,2016,29(07):96.
 YAN Yan,SUN Jianqin,JIANG Bingyu,et al.Clinical Effects of Integrative Medicine in Treating Chronic Obstructive Pulmonary Disease of Senile Patients at Acute Exacerbation[J].Western Journal of Traditional Chinese Medicine,2016,29(01):96.
[9]施巍,苟小军,王道才,等.刺络放血法治疗慢性阻塞性肺疾病急性加重期48例[J].西部中医药,2017,30(02):96.
 SHI Wei,GOU Xiaojun,WANG Daocai,et al.Blood-letting Therapy in Treating 48 Cases of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Stage[J].Western Journal of Traditional Chinese Medicine,2017,30(01):96.
[10]郭晓燕,腾飞,张惠勇.川芎平喘合剂治疗慢性阻塞性肺疾病的随机对照研究[J].西部中医药,2018,31(01):1.
 GUO Xiaoyan,TENG Fei,ZHANG Huiyong.A Randomized, Controlled Study of ChuanXiong PingChuan Mixture in Treating Chronic Obstructive Pulmonary Disease[J].Western Journal of Traditional Chinese Medicine,2018,31(01):1.

备注/Memo

备注/Memo:
李晓梅(1980—),女,副主任医师。研究方向:呼吸系统疾病的中医药防治。辽宁省科学技术计划项目(2015225015)。
更新日期/Last Update: 2022-01-15